Hyperkalemia in women with acne exposed to oral spironolactone: A retrospective study from the RADAR (Research on Adverse Drug Events and Reports) program
Purpose: The necessity of serum potassium monitoring for healthy women who are prescribed spironolactone for acne has been debated. The aim of this study was to compare the incidence of hyperkalemia in women 18 to 45 years of age to that in women 46 to 65 years of age, when treated with oral spirono...
Main Authors: | Rebecca M. Thiede, Supriya Rastogi, Beatrice Nardone, Lauren M. Sadowsky, Stephanie M. Rangel, Dennis P. West, Bethanee J. Schlosser |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-07-01
|
Series: | International Journal of Women's Dermatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352647519300371 |
Similar Items
-
Spironolactone-induced hypersensitivity in a patient with acne vulgaris
by: Bipin Mehta, et al.
Published: (2016-01-01) -
Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease
by: Chen-Ta Yang, et al.
Published: (2018-11-01) -
Spironolactone for the treatment of acne in women, a retrospective study of 110 patients
by: J.W. Charny, BS, et al.
Published: (2017-06-01) -
Efficacy and safety of topical spironolactone 5% cream in the treatment of acne: A pilot study
by: Azin Ayatollahi, et al.
Published: (2021-09-01) -
FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
by: Alexandra Poinas, et al.
Published: (2020-06-01)